Tag: Xiang Li

BioDuro launches AI-driven COVID-19 nanobody therapeutic program

pharmanewsdaily- March 27, 2020

BioDuro said that it has launched a COVID-19 nanobody therapeutic program by leveraging its biologics discovery platform, which makes use of artificial intelligence computing and ... Read More